[go: up one dir, main page]

DK332888D0 - FACTOR VIII: C-DERIVATIVE, ITS MANUFACTURING AND USE - Google Patents

FACTOR VIII: C-DERIVATIVE, ITS MANUFACTURING AND USE

Info

Publication number
DK332888D0
DK332888D0 DK332888A DK332888A DK332888D0 DK 332888 D0 DK332888 D0 DK 332888D0 DK 332888 A DK332888 A DK 332888A DK 332888 A DK332888 A DK 332888A DK 332888 D0 DK332888 D0 DK 332888D0
Authority
DK
Denmark
Prior art keywords
derivative
manufacturing
factor viii
viii
factor
Prior art date
Application number
DK332888A
Other languages
Danish (da)
Other versions
DK332888A (en
Inventor
Klaus-Dieter Langner
Egon Amann
Hans Kuepper
Gerd Zettlmeissl
Bernard Huber
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of DK332888D0 publication Critical patent/DK332888D0/en
Publication of DK332888A publication Critical patent/DK332888A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK332888A 1987-06-19 1988-06-17 FACTOR VIII: C-DERIVATIVE, ITS MANUFACTURING AND USE DK332888A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873720246 DE3720246A1 (en) 1987-06-19 1987-06-19 FACTOR VIII: C-LIKE MOLECULE WITH COAGULATION ACTIVITY

Publications (2)

Publication Number Publication Date
DK332888D0 true DK332888D0 (en) 1988-06-17
DK332888A DK332888A (en) 1988-12-20

Family

ID=6329877

Family Applications (1)

Application Number Title Priority Date Filing Date
DK332888A DK332888A (en) 1987-06-19 1988-06-17 FACTOR VIII: C-DERIVATIVE, ITS MANUFACTURING AND USE

Country Status (8)

Country Link
EP (1) EP0295597A3 (en)
JP (1) JPS6425799A (en)
KR (1) KR890000666A (en)
AU (1) AU609829B2 (en)
DE (1) DE3720246A1 (en)
DK (1) DK332888A (en)
FI (1) FI882890A (en)
PT (1) PT87752B (en)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE468050C (en) * 1991-03-15 1998-04-27 Pharmacia & Upjohn Ab Recombinant human factor VIII derivative
US5661008A (en) * 1991-03-15 1997-08-26 Kabi Pharmacia Ab Recombinant human factor VIII derivatives
AU6456096A (en) * 1995-07-11 1997-02-10 Chiron Corporation Lysine 1689 factor viii:c polypeptide analogs
US8183344B2 (en) 1996-04-24 2012-05-22 University Of Michigan Inactivation resistant factor VIII
CA2252896C (en) 1996-04-24 2009-03-10 The Regents Of The University Of Michigan Inactivation resistant factor viii
EP1038959A1 (en) 1999-03-17 2000-09-27 Aventis Behring Gesellschaft mit beschränkter Haftung Factor VIII without B-domain, comprising one or more insertions of a truncated intron I of factor IX
EP1233064A1 (en) 2001-02-09 2002-08-21 Aventis Behring Gesellschaft mit beschränkter Haftung Modified factor VIII cDNA and its use for the production of factor VIII
TWI353991B (en) 2003-05-06 2011-12-11 Syntonix Pharmaceuticals Inc Immunoglobulin chimeric monomer-dimer hybrids
US7855279B2 (en) 2005-09-27 2010-12-21 Amunix Operating, Inc. Unstructured recombinant polymers and uses thereof
MX2011008094A (en) 2009-02-03 2012-02-13 Amunix Operating Inc Extended recombinant polypeptides and compositions comprising same.
AU2010290131C1 (en) 2009-08-24 2015-12-03 Amunix Operating Inc. Coagulation factor VII compositions and methods of making and using same
PT2482841T (en) 2009-10-02 2019-03-01 Childrens Hospital Philadelphia Compositions and methods for enhancing coagulation factor viii function
SG10201907152YA (en) 2009-12-06 2019-09-27 Bioverativ Therapeutics Inc Factor viii-fc chimeric and hybrid polypeptides, and methods of use thereof
CN103180439A (en) 2010-07-09 2013-06-26 比奥根艾迪克依蒙菲利亚公司 Chimeric clotting factors
EP2591101B1 (en) 2010-07-09 2018-11-07 Bioverativ Therapeutics Inc. Systems for factor viii processing and methods thereof
US9486507B2 (en) 2011-06-10 2016-11-08 Biogen Ma Inc. Pro-coagulant compounds and methods of use thereof
TWI764092B (en) 2011-07-08 2022-05-11 美商百歐維拉提夫治療公司 Factor viii chimeric and hybrid polypeptides, and methods of use thereof
EA028914B1 (en) 2011-07-25 2018-01-31 Байоджен Хемофилия Инк. Assays to monitor bleeding disorders
US9394353B2 (en) 2011-10-18 2016-07-19 Csl Limited Method for improving the stability of purified factor VIII after reconstitution
KR102212098B1 (en) 2012-01-12 2021-02-03 바이오버라티브 테라퓨틱스 인크. Chimeric factor viii polypeptides and uses thereof
JP6234378B2 (en) 2012-01-12 2017-11-22 バイオジェン・エムエイ・インコーポレイテッドＢｉｏｇｅｎ ＭＡ Ｉｎｃ． Method for reducing immunogenicity against factor VIII in an individual undergoing factor VIII therapy
CA2864904C (en) 2012-02-15 2023-04-25 Amunix Operating Inc. Factor viii compositions and methods of making and using same
LT2822577T (en) 2012-02-15 2019-03-25 Bioverativ Therapeutics Inc. Recombinant factor viii proteins
JP2015521589A (en) 2012-06-08 2015-07-30 バイオジェン・エムエイ・インコーポレイテッドＢｉｏｇｅｎ ＭＡ Ｉｎｃ． Procoagulant compounds
EP2863940A4 (en) 2012-06-08 2016-08-10 Biogen Ma Inc Chimeric clotting factors
EP3404105A1 (en) 2012-07-06 2018-11-21 Bioverativ Therapeutics Inc. Cell line expressing single chain factor viii polypeptides and uses thereof
NZ703366A (en) 2012-07-11 2018-03-23 Amunix Operating Inc Factor viii complex with xten and von willebrand factor protein, and uses thereof
WO2014018777A2 (en) 2012-07-25 2014-01-30 Biogen Idec Ma Inc. Blood factor monitoring assay and uses thereof
WO2014063108A1 (en) 2012-10-18 2014-04-24 Biogen Idec Ma Inc. Methods of using a fixed dose of a clotting factor
WO2014070953A1 (en) 2012-10-30 2014-05-08 Biogen Idec Ma Inc. Methods of Using FVIII Polypeptide
FI3889173T3 (en) 2013-02-15 2023-10-02 Bioverativ Therapeutics Inc Optimized factor viii gene
EP3666283B1 (en) 2013-03-15 2022-06-08 Bioverativ Therapeutics Inc. Factor viii polypeptide formulations
EA201592022A1 (en) 2013-06-28 2016-05-31 Байоджен Ма Инк. Fragmented by thrombinom LINKER, CONTAINING XTEN, AND ITS APPLICATION
EP3043813B1 (en) 2013-08-08 2021-01-13 Bioverativ Therapeutics Inc. Purification of chimeric fviii molecules
EP3033097B1 (en) 2013-08-14 2021-03-10 Bioverativ Therapeutics Inc. Factor viii-xten fusions and uses thereof
WO2015070014A1 (en) 2013-11-08 2015-05-14 Biogen Idec Ma Inc. Procoagulant fusion compound
EP4332839A3 (en) 2013-12-06 2024-06-05 Bioverativ Therapeutics Inc. Population pharmacokinetics tools and uses thereof
DK4176894T3 (en) 2014-01-10 2024-05-27 Bioverativ Therapeutics Inc CHIMERIC FACTOR VIII PROTEINS AND USES THEREOF
WO2015120056A1 (en) 2014-02-04 2015-08-13 Biogen Ma Inc. Use of cation-exchange chromatography in the flow-through mode to enrich post-translational modifications
MA40864A (en) 2014-10-31 2017-09-05 Biogen Ma Inc HYPOTAURINE, GABA, BETA-ALANINE AND CHOLINE FOR THE REGULATION OF THE ACCUMULATION OF RESIDUAL BY-PRODUCTS IN MAMMAL CELL CULTURE PROCESSES
CN108472337B (en) 2015-08-03 2022-11-25 比奥贝拉蒂治疗公司 Factor IX fusion proteins and methods of making and using same
HRP20221089T1 (en) 2016-02-01 2022-11-25 Bioverativ Therapeutics Inc. Optimized factor viii genes
JP2020500874A (en) 2016-12-02 2020-01-16 バイオベラティブ セラピューティクス インコーポレイテッド Method of treating hemophilic arthropathy using chimeric clotting factor
CN110520149A (en) 2016-12-02 2019-11-29 比奥维拉迪维治疗股份有限公司 Method of inducing immune tolerance to coagulation factors
US12168776B2 (en) 2017-08-09 2024-12-17 Bioverativ Therapeutics Inc. Nucleic acid molecules and uses thereof
AU2018338608A1 (en) 2017-09-27 2020-04-09 Sigilon Therapeutics, Inc. Methods, compositions, and implantable elements comprising active cells
AU2019215063A1 (en) 2018-02-01 2020-09-03 Bioverativ Therapeutics, Inc. Use of lentiviral vectors expressing Factor VIII
IL312315A (en) 2018-04-04 2024-06-01 Sigilon Therapeutics Inc Implantable particles and related methods
US20210145889A1 (en) 2018-04-04 2021-05-20 Sigilon Therapeutics, Inc. Methods, compositions, and implantable elements comprising stem cells
WO2019222682A1 (en) 2018-05-18 2019-11-21 Bioverativ Therapeutics Inc. Methods of treating hemophilia a
CA3108799A1 (en) 2018-08-09 2020-02-13 Bioverativ Therapeutics Inc. Nucleic acid molecules and uses thereof for non-viral gene therapy
UY38389A (en) 2018-09-27 2020-04-30 Sigilon Therapeutics Inc IMPLANTABLE DEVICES FOR CELLULAR THERAPY AND RELATED METHODS
US20220233650A1 (en) 2019-06-19 2022-07-28 Bioverativ Therapeutics Inc. Recombinant factor viii-fc for treating hemophilia and low bone mineral density
JP2023537565A (en) 2020-06-24 2023-09-04 バイオベラティブ セラピューティクス インコーポレイテッド Methods for removing free factor VIII from preparations of lentiviral vectors modified to express proteins
TW202323274A (en) 2021-08-23 2023-06-16 美商百歐維拉提夫治療公司 Optimized factor viii genes
TW202346327A (en) 2021-09-30 2023-12-01 美商百歐維拉提夫治療公司 Nucleic acids encoding factor viii polypeptides with reduced immunogenicity
WO2024081309A1 (en) 2022-10-11 2024-04-18 Sigilon Therapeutics, Inc. Engineered cells and implantable elements for treatment of disease
WO2024081310A1 (en) 2022-10-11 2024-04-18 Sigilon Therapeutics, Inc. Engineered cells and implantable elements for treatment of disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR910006424B1 (en) * 1985-08-21 1991-08-24 인코텍스 비.브이 Manufacturing method of knitted briefs
US5451521A (en) * 1986-05-29 1995-09-19 Genetics Institute, Inc. Procoagulant proteins
IL83192A (en) * 1986-07-18 1992-11-15 Gist Brocades Nv Method for the preparation of proteins with factor viii activity by microbial host cells;expression vectors,host cells,antibodies
WO1988005825A1 (en) * 1987-01-30 1988-08-11 Biogen N.V. A method for producing factor viii in high yield
EP0294910B1 (en) * 1987-06-12 1996-09-11 Immuno Ag Novel proteins with factor VIII activity, process for their preparation using genetically engineered cells and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
EP0295597A3 (en) 1990-05-02
DK332888A (en) 1988-12-20
AU1810388A (en) 1988-12-22
EP0295597A2 (en) 1988-12-21
PT87752A (en) 1988-07-01
DE3720246A1 (en) 1988-12-29
AU609829B2 (en) 1991-05-09
PT87752B (en) 1992-10-30
KR890000666A (en) 1989-03-16
FI882890A0 (en) 1988-06-16
FI882890A (en) 1988-12-20
JPS6425799A (en) 1989-01-27

Similar Documents

Publication Publication Date Title
DK332888D0 (en) FACTOR VIII: C-DERIVATIVE, ITS MANUFACTURING AND USE
DK656189A (en) STABILIZED SUCRALOS COMPLEX, ITS MANUFACTURING AND USE
DK223388D0 (en) SUBSTRATE, ITS MANUFACTURING AND USE
DK537089D0 (en) SYNERGISTIC SWEATER, ITS MANUFACTURING AND USE
NO851563L (en) FUNCTIONAL, HUMAN FACTOR VIII AND PROCEDURES FOR PRODUCING THEREOF.
DK609689A (en) FOLIAMINATE AND ITS USE
DK555586D0 (en) HARDENING PRODUCT, ITS MANUFACTURING AND USE
NO882385L (en) POLYPEPTIME AND PRODUCTION THEREOF.
DK285388A (en) PEPTIME AND ITS USE
NO891334L (en) SUPERLY MATERIAL AND PROCEDURE FOR ITS MANUFACTURING.
DK87487D0 (en) FUNGICID AGENT, ITS MANUFACTURING AND USE
DK668988A (en) MONOAZOPIGMENTS, THEIR MANUFACTURING AND USE
DK388489A (en) SYNERGISTIC SWEATER, ITS MANUFACTURING AND USE
DK525687D0 (en) ENZYMOUS PREPARATION, ITS MANUFACTURING AND USE
DK408688D0 (en) AUTODESINFINING PRINT MATERIAL, ITS MANUFACTURING AND USE
NO881902D0 (en) SOPPAROMA AND MANUFACTURING THEREOF.
NO884120D0 (en) SUPERVISIVE MATERIAL AND PROCEDURE FOR ITS MANUFACTURING.
DK125087D0 (en) EFOMYCIN G., ITS MANUFACTURING AND USE
DK285288A (en) PEPTIME AND ITS USE
DK144084A (en) MAKROLID, ITS MANUFACTURING AND USE
DK587588A (en) POLYPEPTID, ITS USE AND MANUFACTURING
DK587688A (en) POLYPEPTID, ITS USE AND MANUFACTURING
DK690587D0 (en) TETRAPEPTIME, ITS MANUFACTURING AND USE
DK545287A (en) HYBRID PLASMID ITS MANUFACTURING AND USE
DK294987D0 (en) PLASMID, CALLED PADE161, ITS MANUFACTURING AND USE

Legal Events

Date Code Title Description
ATS Application withdrawn